Literature DB >> 6287701

Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP.

H L Bachrach, D O Morgan, P D McKercher, D M Moore, B H Robertson.   

Abstract

Peptide fragments were obtained from the immunogenic capsid protein VP3, ca. 24 kilodaltons (kd), of foot-and-mouth disease virus type A12 119ab by three procedures: (1) spontaneous proteolysis of in virion VP3 in tissue cultures to produce a 15 kd peptide, designated S fragment; (2) trypsin treatment of purified virus to produce a 16 kg peptide, designated T fragment; and (3) cyanogen bromide cleavage of purified VP3 to produce a 13 kd fragment. Following isolation and purification by gel electrophoresis, VP3 and each of the three fragments were immunogenic for livestock. Lyophilization appeared to impair the immunogenicity of VP3. In addition, viruses containing VP3 fragments produced either by the spontaneous- or trypsin-induced proteolysis were as immunogenic as virus with its VP3 intact. Amino acid sequencing of N-terminal regions revealed that the S fragment was homologous with the N-terminus of VP3, whereas the 13 kd fragment possessed a unique N-terminus. Thus, putative common immunogenic amino acid sequences would appear to reside within an overlap region of the 15 kd S and 13 kd fragments. Sequencing of cDNA prepared to viral genome RNA provided three kinds of information: it (1) placed the above overlap region in the second and third quarters of VP3; (2) demonstrated that the codons for the C-terminus of VP1 and N-terminus of VP3 are contiguous; and (3) supported earlier evidence that these same codons program a chain reversal where VP1 and VP3 are joined in the precursor polyprotein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287701     DOI: 10.1016/0378-1135(82)90020-7

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  9 in total

1.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

Authors:  B Baxt; V Vakharia; D M Moore; A J Franke; D O Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

2.  Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70.

Authors:  J H Nunberg; G Rodgers; J H Gilbert; R M Snead
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

3.  Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus.

Authors:  A Cheung; J DeLamarter; S Weiss; H Küpper
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

4.  Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A.

Authors:  G N Weddell; D G Yansura; D J Dowbenko; M E Hoatlin; M J Grubman; D M Moore; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodies.

Authors:  M V Borca; A E Garmendia; B Baxt; D M Moore; S Srikumaran; D O Morgan
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

6.  Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds.

Authors:  Chenwen Xiao; Zahid Iqbal Rajput; Diwen Liu; Songhua Hu
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

7.  Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.

Authors:  B H Robertson; D M Moore; M J Grubman; D G Kleid
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

8.  Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.

Authors:  B Baxt; D O Morgan; B H Robertson; C A Timpone
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

9.  Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa.

Authors:  M Chitray; T A P de Beer; W Vosloo; F F Maree
Journal:  Arch Virol       Date:  2013-11-13       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.